Petrik J
Scottish National Blood Transfusion Service and Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.
Transfus Med. 2006 Aug;16(4):233-47. doi: 10.1111/j.1365-3148.2006.00673.x.
Microarrays were designed to monitor the expression of many genes in parallel, providing substantially more information than Northern blots or reverse transcription polymerase chain reaction analysing one or few genes at a time. The large sequencing projects provided the content for detailed expression studies under a variety of stimuli and conditions. The human genome project identified around 30 000 human genes. Estimated number of protein products is, however, 10-30 times higher, mainly due to the alternative splicing and post-translational modifications. The identification of gene functions requires both genomic and proteomic approaches, including protein microarrays, and numerous current microarray projects focus on deciphering gene expression patterns under a variety of conditions. Establishing the key genes and gene products for particular conditions opens the way for diagnostic applications using multiparameter, high-throughput assays. This format can also accommodate existing blood screening assays, potentially providing a single testing platform. This review considers the progress in diagnostic microarrays in a wider context of in vitro diagnostics field.
微阵列旨在同时监测许多基因的表达,比一次分析一个或几个基因的Northern印迹法或逆转录聚合酶链反应提供的信息要多得多。大型测序项目为在各种刺激和条件下进行详细的表达研究提供了内容。人类基因组计划鉴定出约30000个人类基因。然而,蛋白质产物的估计数量要高10到30倍,这主要是由于可变剪接和翻译后修饰。基因功能的鉴定需要基因组和蛋白质组方法,包括蛋白质微阵列,目前许多微阵列项目专注于解读各种条件下的基因表达模式。确定特定条件下的关键基因和基因产物为使用多参数、高通量检测的诊断应用开辟了道路。这种形式还可以容纳现有的血液筛查检测,有可能提供一个单一的检测平台。本综述在体外诊断领域的更广泛背景下考虑诊断微阵列的进展。